Docetaxel and cisplatin versus M-VAC in advanced urothelial carcinoma: A multicenter, randomized, phase III study conducted by the Hellenic Cooperative Oncology Group

Reviewer: Neha Vapiwala, MD
OncoLink
Ultima Vez Modificado: 2 de junio del 2003

Translation for this article does not exist